Literature DB >> 20807740

Neuroprotection and brain cholesterol biosynthesis in Huntington's disease.

Marta Valenza, Elena Cattaneo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20807740      PMCID： PMC2941308          DOI： 10.1073/pnas.1006783107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.

Authors:  Ruth Luthi-Carter; David M Taylor; Judit Pallos; Emmanuel Lambert; Allison Amore; Alex Parker; Hilary Moffitt; Donna L Smith; Heike Runne; Ozgun Gokce; Alexandre Kuhn; Zhongmin Xiang; Michele M Maxwell; Steven A Reeves; Gillian P Bates; Christian Neri; Leslie M Thompson; J Lawrence Marsh; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

2.  Getting a handle on Huntington's disease: the case for cholesterol.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Gen Sobue
Journal:  Nat Med       Date:  2009-03       Impact factor: 53.440

3.  Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.

Authors:  Diana Zala; Alexandra Benchoua; Emmanuel Brouillet; Valérie Perrin; Marie-Claude Gaillard; Anne D Zurn; Patrick Aebischer; Nicole Déglon
Journal:  Neurobiol Dis       Date:  2005-07-11       Impact factor: 5.996

4.  Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.

Authors:  Marta Valenza; Valerio Leoni; Joanna M Karasinska; Lara Petricca; Jianjia Fan; Jeffrey Carroll; Mahmoud A Pouladi; Elisa Fossale; Huu Phuc Nguyen; Olaf Riess; Marcy MacDonald; Cheryl Wellington; Stefano DiDonato; Michael Hayden; Elena Cattaneo
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

Review 5.  Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Authors:  Chiara Zuccato; Marta Valenza; Elena Cattaneo
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312
  5 in total
  3 in total

1.  Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Authors:  Jane Y Chen; Conny Tran; Lin Hwang; Gang Deng; Michael E Jung; Kym F Faull; Michael S Levine; Carlos Cepeda
Journal:  J Huntingtons Dis       Date:  2016

2.  Pitfalls in the detection of cholesterol in Huntington's disease models.

Authors:  Manuela Marullo; Marta Valenza; Valerio Leoni; Claudio Caccia; Chiara Scarlatti; Agnese De Mario; Chiara Zuccato; Stefano Di Donato; Ernesto Carafoli; Elena Cattaneo
Journal:  PLoS Curr       Date:  2012-10-11

3.  Robust MR-based approaches to quantifying white matter structure and structure/function alterations in Huntington's disease.

Authors:  Jessica J Steventon; Rebecca C Trueman; Anne E Rosser; Derek K Jones
Journal:  J Neurosci Methods       Date:  2015-08-31       Impact factor: 2.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.